LUNG

Pulmonx Corporation

8.01 USD
-0.06 (-0.74%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Pulmonx Corporation stock is up 6.8% since 30 days ago. The next earnings date is Jul 31, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 May’s closed higher than April. 100% of analysts rate it a buy.

About Pulmonx Corporation

Pulmonx Corporation provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service. It serves emphysema patients in the United States, Europe, the Middle East, Africa, Asia-Pacific and internationally.